475 research outputs found
Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgery
Objective: Experimental models show that apolipoprotein CI (apoCI) binds and enhances the inflammatory response to endotoxin. We studied in patients undergoing cardiopulmonary bypass surgery (CPB) and experiencing endotoxemia during reperfusion whether plasma apoCI levels correlate with the inflammatory response and perioperative cytokine release. Design: Prospective, observational, clinical cohort study. Setting: Operating room (OR) and intensive care unit (ICU) of a university hospital. Patients: One hundred fifty-nine consecutive patients > 18 years of age (66% males (n = 105), median age 65 and 67 years for males and females, respectively) undergoing elective cardiothoracic surgery with cardiopulmonary bypass. Interventions: None. Measurements: Baseline apoCI, apoCIII, total cholesterol and triglyceride levels, and perioperative endotoxin and TNF-α levels were determined. Results: High preoperative plasma apoCI, but not apoCIII, levels were associated (p < 0.05) with increased perioperative levels of TNF-α in patients experiencing endotoxemia. This association was not observed in patients without endotoxemia. Conclusion: High plasma apoCI is positively related to proinflammatory response in patients experiencing endotoxemia and confirms the observations in animal models. © 2008 The Author(s)
Relationship between the Daily Rhythm of Distal Skin Temperature and Brown Adipose Tissue 18F-FDG Uptake in Young Sedentary Adults
The present study examines whether the daily rhythm of distal skin
temperature (DST) is associated with brown adipose tissue (BAT) metabolism
as determined by 18F-fluorodeoxyglucose (18F-FDG) uptake in young adults.
Using a wireless thermometer (iButton) worn on the nondominant wrist, DST
was measured in 77 subjects (26% male; age 22 ± 2 years; body mass index 25.2
± 4.8 kg/m2) for 7 consecutive days. The temperatures to which they were
habitually exposed over the day were also recorded. The interday stability of
DST was calculated from the collected data, along with the intraday variability
and relative amplitude; the mean temperature of the 5 and 10 consecutive
hours with the maximum and minimum DST values, respectively; and when
these hours occurred. Following exposure to cold, BAT volume and mean and
peak standardized 18F-FDG uptake (SUVmean and SUVpeak) were determined for
each subject via static 18F-FDG positron emission tomography/computed
tomography scanning. Relative amplitude and the time at which the 10 consecutive
hours of minimum DST values occurred were positively associated
with BAT volume, SUVmean, and SUVpeak (p ≤ 0.02), whereas the mean DST of
that period was inversely associated with the latter BAT variables (p ≤ 0.01).
The interday stability and intraday variability of the DST were also associated
(directly and inversely, respectively) with BAT SUVpeak (p ≤ 0.02 for both). All
of these associations disappeared, however, when the analyses were adjusted
for the ambient temperature to which the subjects were habitually exposed. Thus, the relationship between the daily rhythm of DST and BAT activity estimated
by 18F-FDG uptake is masked by environmental and likely behavioral
factors. Of note is that those participants exposed to the lowest ambient temperature
showed 3 to 5 times more BAT volume and activity compared with
subjects who were exposed to a warmer ambient temperature
Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidemia and atherosclerosis development
Aims Brown fat activation accelerates the uptake of cholesterol-enriched remnants by the liver and thereby lowers plasma cholesterol, consequently protecting against atherosclerosis development. Hepatic cholesterol is then converted into bile acids (BAs) that are secreted into the intestine and largely maintained within the enterohepatic circulation. We now aimed to evaluate the effects of prolonged brown fat activation combined with inhibition of intestinal BA reabsorption on plasma cholesterol metabolism and atherosclerosis development and results APOE∗3-Leiden.CETP mice with humanized lipoprotein metabolism were treated for 9 weeks with the selective b3-adrenergic receptor (AR) agonist CL316,243 to substantially activate brown fat. Prolonged b3-AR agonism reduced faecal BA excretion (-31%), while markedly increasing plasma levels of total BAs (258%), cholic acid-derived BAs (295%), and chenodeoxycholic acid-derived BAs (217%), and decreasing the expression of hepatic genes involved in BA production. In subsequent experiments, mice were additionally treated with the BA sequestrant Colesevelam to inhibit BA reabsorption. Concomitant intestinal BA sequestration increased faecal BA excretion, normalized plasma BA levels, and reduced hepatic cholesterol. Moreover, concomitant BA sequestration further reduced plasma total cholesterol (-49%) and non-high-density lipoprotein cholesterol (-56%), tended to further attenuate atherosclerotic lesion area (-54%). Concomitant BA sequestration further increased the proportion of lesion-free valves (34%) and decreased the relative macrophage area within the lesion (-26%), thereby further increasing the plaque stability index (44%). Conclusion BA sequestration prevents the marked accumulation of plasma BAs as induced by prolonged brown fat activation, thereby further improving cholesterol metabolism and reducing atherosclerosis development. These data suggest that combining brown fat activation with BA sequestration is a promising new therapeutic strategy to reduce hyperlipidaemia and cardiovascular diseases
Equal Time Correlations in Haldane Gap Antiferromagnets
The antiferromagnetic Heisenberg chain both with and without single ion
anisotropy is studied. Using the recently proposed density matrix
renormalization group technique we calculate the energy gaps as well as several
different correlation functions. The two gaps, ,
along with associated correlation lengths and velocities are determined. The
numerical results are shown to be in good agreement with theoretical
predictions derived from the nonlinear sigma model and a free boson model. We
also study the excitations that occur at the ends of open chains; in
particular we study the behavior associated with open boundary conditions,
using a model of spins coupled to the free bosons.Comment: 32 pages, uufiles encoded REVTEX 3.0, 19 postscript figures included,
UBCTP-93-02
The impact of using BARCIST 1.0 criteria on quantification of BAT volume and activity in three independent cohorts of adults
Human brown adipose tissue (BAT) is commonly assessed by cold-induced 18F-fluorodeoxyglucose
(FDG) PET-CT using several quantification criteria. Uniform criteria for data analysis became available
recently (BARCIST 1.0). We compared BAT volume and activity following BARCIST 1.0 criteria
against the most commonly used criteria [Hounsfield Units (HU):-250, -50, standardized uptake
value (SUV):2.0; HU: Not applied, SUV:2.0 and HU:-180, -10, SUV:1.5] in a prospective study using
three independent cohorts of men including young lean adults, young overweight/obese adults and
middle-aged overweight/obese adults. BAT volume was the most variable outcome between criteria.
While BAT volume calculated using the HU: NA; SUV: 2.0 criteria was up to 207% higher than the BAT
volume calculated based on BARCIST 1.0 criteria, it was up to 57% lower using the HU: -250, -50; SUV:
2.0 criteria compared to the BARCIST 1.0. Similarly, BAT activity (expressed as SUVmean) also differed
between different thresholds mainly because SUVmean depends on BAT volume. SUVpeak was the most
consistent BAT outcome across the four study criteria. Of note, we replicated these findings in three
independent cohorts. In conclusion, BAT volume and activity as determined by 18F-FDG-PET/CT highly
depend on the quantification criteria used. Future human BAT studies should conduct sensitivity
analysis with different thresholds in order to understand whether results are driven by the selected HU
and/or SUV thresholds. The design of the present study precludes providing any conclusive threshold,
but before more definitive thresholds for HU and SUV are available, we support the use of BARCIST 1.0
criteria to facilitate interpretation of BAT characteristics between research groups
Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile
According to the current dogma, cholesteryl ester transfer protein (CETP) decreases high-density lipoprotein (HDL)-cholesterol (C) and increases low-density lipoprotein (LDL)-C. However, detailed insight into the effects of CETP on lipoprotein subclasses is lacking. Therefore, we used a Mendelian randomization approach based on a genetic score for serum CETP concentration (rs247616, rs12720922 and rs1968905) to estimate causal effects per unit (mu g/mL) increase in CETP on 159 standardized metabolic biomarkers, primarily lipoprotein subclasses. Metabolic biomarkers were measured by nuclear magnetic resonance (NMR) in 5672 participants of the Netherlands Epidemiology of Obesity (NEO) study. Higher CETP concentrations were associated with less large HDL (largest effect XL-HDL-C, P = 6 x 10(-22)) and more small VLDL components (largest effect S-VLDL cholesteryl esters, P = 6 x 10(-6)). No causal effects were observed with LDL subclasses. All these effects were replicated in an independent cohort from European ancestry (MAGNETIC NMR GWAS; n similar to 20,000). Additionally, we assessed observational associations between ELISA-measured CETP concentration and metabolic measures. In contrast to results from Mendelian randomization, observationally, CETP concentration predominantly associated with more VLDL, IDL and LDL components. Our results show that CETP is an important causal determinant of HDL and VLDL concentration and composition, which may imply that the CETP inhibitor anacetrapib decreased cardiovascular disease risk through specific reduction of small VLDL rather than LDL. The contrast between genetic and observational associations might be explained by a high capacity of VLDL, IDL and LDL subclasses to carry CETP, thereby concealing causal effects on HDL.Peer reviewe
Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation
Liver X receptor (LXR) agonism has theoretical potential for treating NAFLD/NASH, but synthetic agonists induce hyperlipidemia in preclinical models. Desmosterol, which is converted by Δ24-dehydrocholesterol reductase (DHCR24) into cholesterol, is a potent endogenous LXR agonist with anti-inflammatory properties. We aimed to investigate the effects of DHCR24 inhibition on NAFLD/NASH development. Here, by using APOE*3-Leiden. CETP mice, a well-established translational model that develops diet-induced human-like NAFLD/NASH characteristics, we report that SH42, a published DHCR24 inhibitor, markedly increases desmosterol levels in liver and plasma, reduces hepatic lipid content and the steatosis score, and decreases plasma fatty acid and cholesteryl ester concentrations. Flow cytometry showed that SH42 decreases liver inflammation by preventing Kupffer cell activation and monocyte infiltration. LXRα deficiency completely abolishes these beneficial effects of SH42. Together, the inhibition of DHCR24 by SH42 prevents diet-induced hepatic steatosis and inflammation in a strictly LXRα-dependent manner without causing hyperlipidemia. Finally, we also showed that SH42 treatment decreased liver collagen content and plasma alanine transaminase levels in an established NAFLD model. In conclusion, we anticipate that pharmacological DHCR24 inhibition may represent a novel therapeutic strategy for treatment of NAFLD/NASH.</p
ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
BACKGROUND: The ɛ2, ɛ3, and ɛ4 alleles of the apolipoprotein E gene (APOE) encode three isoforms, apoE2, E3, and E4, respectively. The apoE isoforms circulate in different plasma concentrations, but plasma concentrations of the same isoform also differ between individuals. Whereas the isoforms have been associated with cardiovascular disease, the relation between plasma apoE levels and cardiovascular disease is unknown. METHODS AND FINDINGS: We assessed APOE genotypes, plasma levels of apoE, cardiovascular risk factors, and mortality in a population-based sample of 546 individuals aged 85 y who participated in the Leiden 85-plus Study and were prospectively followed for specific causes of death for 5 y. Participants in the highest tertile of apoE levels suffered a twofold-increased risk of cardiovascular mortality (hazard ratio compared to lowest tertile, 2.08; 95% confidence interval [CI], 1.30 to 3.33). Among the 324 participants with the ɛ3ɛ3 genotype, the hazard from cardiovascular disease was threefold increased (highest versus lowest tertile 3.01; 95% CI 1.60 to 5.66), with similar estimates for men and women. Other causes of death were not increased significantly. Plasma levels of apoE in ɛ3ɛ3 participants were positively correlated with total cholesterol ( p < 0.001), low-density lipoprotein cholesterol ( p < 0.001) and triglycerides ( p < 0.001) and negatively with high-density lipoprotein cholesterol levels ( p = 0.010). Adjustment for plasma lipids did not change the hazard ratios, whereas interaction was absent. The risk associated with high levels of apoE, however, was strongest in participants from the lowest tertile of C-reactive protein (CRP) levels and absent in those from the highest tertile ( p (interaction) < 0.001). Among participants from the lowest tertile of CRP levels, those with a high apoE levels had a significantly steeper increase in CRP than those with low apoE levels ( p = 0.020). Similar cardiovascular mortality risks as in ɛ3ɛ3 participants were found in ɛ2 and ɛ4 carriers. CONCLUSIONS: In old age, high plasma apoE levels precede an increase of circulating CRP and strongly associates with cardiovascular mortality, independent of APOE genotype and plasma lipids
The superconductor-insulator transition in 2D dirty boson systems
Universal properties of the zero temperature superconductor-insulator
transition in two-dimensional amorphous films are studied by extensive Monte
Carlo simulations of bosons in a disordered medium. We report results for both
short-range and long-range Coulomb interactions for several different points in
parameter space. In all cases we observe a transition from a superconducting
phase to an insulating Bose glass phase. {}From finite-size scaling of our
Monte Carlo data we determine the universal conductivity and the
critical exponents at the transition. The result for bosons with long-range Coulomb interaction is roughly consistent
with experiments reported so far. We also find for bosons with short-range interactions.Comment: Revtex 3.0, 54 pages, 17 figures included, UBCTP-93-01
Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80Clec4fVsig4Ly6C Kupffer Cell Subsets
BACKGROUND: Lipopolysaccharide (LPS) decreases hepatic CETP (cholesteryl ester transfer protein) expression albeit that the underlying mechanism is disputed. We recently showed that plasma CETP is mainly derived from Kupffer cells (KCs). In this study, we investigated the role of KC subsets in the mechanism by which LPS reduces CETP expression. METHODS AND RESULTS: In CETP-transgenic mice, LPS markedly decreased hepatic CETP expression and plasma CETP concentration without affecting hepatic macrophage number. This was paralleled by decreased expression of the resting KC markers C-type lectin domain family 4, member f (Clec4f) and V-set and immunoglobulin domain containing 4 (Vsig4), while expression of the infiltrating monocyte marker lymphocyte antigen 6 complex locus C (Ly6C) was increased. Simultaneously, the ratio of plasma high-density lipoprotein-cholesterol over non-high-density lipoprotein-cholesterol transiently increased. After ablation hepatic macrophages via injection with liposomal clodronate, the reappearance of hepatic gene and protein expression of CETP coincided with Clec4f and Vsig4, but not Ly6C. Double-immunofluorescence staining showed that CETP co-localized with Clec4f+ KCs and not Ly6C+ monocytes. In humans, microarray gene-expression analysis of liver biopsies revealed that hepatic expression and plasma level of CETP both correlated with hepatic VSIG4 expression. LPS administration decreased the plasma CETP concentration in humans. In vitro experiments showed that LPS reduced liver X receptor-mediated CETP expression. CONCLUSIONS: Hepatic expression of CETP is exclusively confined to the resting KC subset (ie, F4/80+Clec4f+Vsig4+Ly6C-). LPS activated resting KCs, leading to reduction of Clec4f and Vsig4 expression and reduction of hepatic CETP expression, consequently decreasing plasma CETP and raising high-density lipoprotein (HDL)-cholesterol. This sequence of events is consistent with the anti-inflammatory role of HDL in the response to LPS and may be relevant as a defense mechanism against bacterial infections
- …